Milestone Pharmaceuticals Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
Milestone Pharmaceuticals Inc. (MIST) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 0 shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2021-05-17
- Milestone Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2021-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Milestone Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2020-03-31 was 7.73K shares.
- Milestone Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-09-30 was 0.00 shares.
- Milestone Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-06-30 was 0.00 shares.
- Milestone Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2020 was 103.50K shares, a 27.62% increase from fiscal 2019.
- Milestone Pharmaceuticals Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2019 was 81.10K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | 103.50K shares 10-K · filed 2021-03-29 | |||
| 2020-03-31 | 7.73K shares 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | 81.10K shares 10-K · filed 2021-03-29 | |||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-13 | 12.20K shares 10-Q · filed 2019-11-13 | |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | 12.20K shares 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | 12.20K shares 10-Q · filed 2019-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |